The 5'-nucleotidase S5nA is Dispensable for Evasion of Phagocytosis and Biofilm Formation in Streptococcus Pyogenes
Overview
Authors
Affiliations
5'-nucleotidases are widespread among all domains of life. The enzymes hydrolyze phosphate residues from nucleotides and nucleotide derivatives. In some pathobiontic bacteria, 5'-nucleotidases contribute to immune evasion by dephosphorylating adenosine mono-, di-, or tri-phosphates, thereby either decreasing the concentration of pro-inflammatory ATP or increasing the concentration of anti-inflammatory adenosine, both acting on purinergic receptors of phagocytic cells. The strict human pathogen Streptococcus pyogenes expresses a surface-associated 5'-nucleotidase (S5nA) under infection conditions that has previously been discussed as a potential virulence factor. Here we show that deletion of the S5nA gene does not significantly affect growth in human blood, evasion of phagocytosis by neutrophils, formation of biofilms and virulence in an infection model with larvae of the greater wax moth Galleria mellonella in S. pyogenes serotypes M6, M18 and M49. Hence, the surface-associated 5'-nucleotidase S5nA seems dispensable for evasion of phagocytosis and biofilm formation in S. pyogenes.
Liu J, Zhang Z, Pu W, Pan X, Li P, Bai Q NPJ Vaccines. 2024; 9(1):216.
PMID: 39543108 PMC: 11564553. DOI: 10.1038/s41541-024-01015-7.
5'-nucleotidases contribute to adenosine-mediated immune evasion and virulence in a mouse model.
Deng S, Li H, Zhou C, Fan J, Zhu F, Jin G Virulence. 2024; 15(1):2401963.
PMID: 39282964 PMC: 11407386. DOI: 10.1080/21505594.2024.2401963.
Immunomodulating Enzymes from -In Pathogenesis, as Biotechnological Tools, and as Biological Drugs.
Happonen L, Collin M Microorganisms. 2024; 12(1).
PMID: 38258026 PMC: 10818452. DOI: 10.3390/microorganisms12010200.
Budziaszek J, Pilarczyk-Zurek M, Dobosz E, Kozinska A, Nowicki D, Obszanska K Infect Immun. 2023; 91(5):e0001623.
PMID: 37097148 PMC: 10187118. DOI: 10.1128/iai.00016-23.
Purinergic Signalling in Group A Pathogenesis.
McEwan T, Sanderson-Smith M, Sluyter R Front Immunol. 2022; 13:872053.
PMID: 35422801 PMC: 9002173. DOI: 10.3389/fimmu.2022.872053.